NCT05522972 Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
| NCT ID | NCT05522972 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nova Southeastern University |
| Condition | Amblyopia |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2022-09-13 |
| Primary Completion | 2029-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2022-09-13 with a primary completion date of 2029-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.
Eligibility Criteria
Inclusion Criteria: * adults and children with normal vision or amblyopia * amblyopia: interocular VA difference of 0.1 logMAR or more Exclusion Criteria: * any ocular pathological conditions, nystagmus
Contact & Investigator
Roger W Li, OD, PhD
PRINCIPAL INVESTIGATOR
Nova Southeastern University College of Optometry
Frequently Asked Questions
Who can join the NCT05522972 clinical trial?
This trial is open to participants of all sexes, studying Amblyopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05522972 currently recruiting?
Yes, NCT05522972 is actively recruiting participants. Contact the research team at wli@nova.edu for enrollment information.
Where is the NCT05522972 trial being conducted?
This trial is being conducted at Fort Lauderdale, United States.
Who is sponsoring the NCT05522972 clinical trial?
NCT05522972 is sponsored by Nova Southeastern University. The principal investigator is Roger W Li, OD, PhD at Nova Southeastern University College of Optometry. The trial plans to enroll 180 participants.